Reliv International, Inc., announced that LunaRich® has earned a new patent from the US Patent and Trademark Office. The composition of matter patent protects the LunaRich technology as it relates to its superior ability to deliver bioactive lunasin to the body. Lunasin is a naturally occurring peptide scientists have identified as the key to many of soy’s documented health benefits.
“This is an exciting step forward for Reliv and for our LunaRich product line,” said Dr. Carl W. Hastings, Reliv vice chairman and chief scientific officer. “We already owned a patent for LunaRich’s ability to reduce LDL cholesterol. Now we have added a patent for the LunaRich material itself. The result is a very strong patent portfolio for a remarkable nutritional ingredient.”
The patent announcement comes only two weeks after Reliv entered into an exclusive license for the intellectual property of Soy Labs LLC related to the nutritional ingredient lunasin. The license covers a previously issued patent and several patent applications (one now granted) related to lunasin and soy-related peptides, proprietary information and manufacturing processes.
LunaRich’s Superior Bioavailability
The amount of lunasin in soybeans varies significantly based on seed, soil and environment. LunaRich uses specially selected soybeans grown exclusively for Reliv with highly concentrated levels of bioactive lunasin.
LunaRich’s unique refinement process retains a more uniform and integrated “shell” of protease inhibitors, which serve as protective chaperone molecules to better protect the lunasin from being destroyed in the stomach. The shell is then broken down to allow for maximum absorption of lunasin in the small intestine, where it can provide the greatest benefit. Learn more about LunaRich’s bioavailability.
“We have demonstrated through our exclusive bioassay, based on lunasin’s proprietary epigenetic mechanism of action, that LunaRich products maintain lunasin’s bioactivity after digestion,” said Dr. Alfredo Galvez, lead scientific advisor at SL Technologies, a Reliv subsidiary. “It is the only test of its kind in the supplement industry and gives Reliv the unique ability to guarantee the bioavailability of lunasin in its LunaRich products. Now, we have a patent to protect the novel formulations that make LunaRich products so effective in providing all the health benefits of lunasin.” Learn more about the benefits of lunasin.
How Lunasin Works
Lunasin is one of the first nutritional compounds identified to affect gene expression and promote optimal health at the epigenetic level. The epigenome, which literally means “beyond the genome,” is a higher level of complexity within the cell. It acts like a dimmer for lights, controlling which genes are used, when they are used and how much they are used.
Lunasin can attach itself to the epigenome. As a result, it can increase expression of important genes needed for normal cell functioning and protect the cells from environmental damage once it occurs. More than 50 published papers from more than 25 research institutions demonstrate lunasin’s multiple health benefits. Learn more about lunasin and epigenetics.
In addition to the LunaRich patents, nine Reliv nutritional formulas have earned US patents: Reliv Classic® for essential daily nutrition, Innergize!® for isotonic hydration, FibRestore® for digestive health, Cellebrate® for weight loss, Arthaffect® for joint health, ReversAge® for anti-aging, GlucAffect® for blood sugar management, ProVantage® for performance nutrition and 24K™ for healthy energy. Note: the patents for Reliv Classic and Innergize! have expired.